What is Leerink Partnrs’ Forecast for SPRY FY2029 Earnings?
ARS Pharmaceuticals, Inc. (NASDAQ:SPRY – Free Report) – Investment analysts at Leerink Partnrs issued their FY2029 earnings per share (EPS) estimates for shares of ARS Pharmaceuticals in a research note issued on Sunday, June 22nd. Leerink Partnrs analyst R. Ruiz forecasts that the company will post earnings per share of $3.55 for the year. The […]
More Stories
More Than 40 Charged in 1st Nationwide SNAP Fraud Crackdown
By Janice Hisle CINCINNATI—The United States’ first nationwide surge against food-assistance fraud has led to charges against more than 40...
5 Charged With Trafficking Guns From North Carolina to Eastern Cities
By Michael Clements The arrest of five people has effectively shut down an alleged gun trafficking operation that armed criminals...
Ilhan Omar, Broken Vetting, and Minnesota’s Billion-Dollar Fraud: The Questions That Will Not Die
By Stephen Zogopoulos, USNN World News The federal investigation into Rep. Ilhan Omar’s immigration history and the massive public-benefits fraud...
Democrats Sue Trump Admin Over Bid to Clean Up Voter Rolls
By Zachary Stieber Senate Minority Leader Chuck Schumer (D-N.Y.) and other Democrats have sued the Trump administration over its effort...
Implementing Freight Management Software: In-House or With Specialist Help?
You’ve picked a freight platform. Now you have to get it live without stopping trucks, missing invoices or losing track...
DOGE Illegally Accessed Data on Government Workers: Judge
By Zachary Stieber A federal judge ruled on Oct. 20 that a department aimed at making the government more efficient...